Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Glaucoma Surgery Devices Market Size & Growth Forecast 2027–2036, By Segments (Surgery Method, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14699| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Glaucoma Surgery Devices Market size was worth USD 1.9 billion in 2026 and is poised to grow at a 4.37% CAGR between 2027 and 2036, crossing USD 2.91 billion by 2036. The industry revenue for 2027 is assessed at USD 1.97 billion.

Base Year Value (2026)
USD 1.9 billion
CAGR (2027-2036)
4.37%
Forecast Year Value (2036)
USD 2.91 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Glaucoma Surgery Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for 39.50% of the market in 2026, supported by advanced ophthalmic infrastructure, high procedure volumes, and widespread adoption of surgical glaucoma treatments.
  • Asia Pacific is projected to grow at a 5.36% CAGR as improving ophthalmic care access, expanding hospital capacity, and broader availability of modern glaucoma procedures increase device adoption.

Segment Momentum

  • Traditional glaucoma surgery held a 37.22% share in 2026 due to its established role in managing advanced glaucoma cases that require substantial intraocular pressure reduction and proven clinical outcomes.
  • Ophthalmic clinics are the fastest-growing end-use segment as more glaucoma procedures shift to specialized outpatient settings focused on efficiency, patient convenience, and minimally invasive techniques.

Market Expansion Drivers

  • Rising prevalence of glaucoma and age-related eye disorders increasing surgical intervention demand.
  • Growing preference for surgical solutions over long-term pharmacological glaucoma management.
  • Government-led vision care awareness and screening programs improving early diagnosis rates.

Leading Market Participants

  • Top companies in the glaucoma surgery devices market include Alcon Inc. (Switzerland), Glaukos Corporation (United States), Carl Zeiss Meditec AG (Germany), Lumenis Ltd. (Israel), Iridex Corporation (United States), AbbVie Inc. (United States), BVI Medical (United States), Ziemer Ophthalmic Systems AG (Switzerland).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 1.9 billion
  • 2027 Estimated Market Size: USD 1.97 billion.
  • Projected Market Size: USD 2.91 billion by 2036
  • Growth Forecast: 4.37% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Traditional Glaucoma Surgery (Surgery Method) | Hospitals (End-use) | Traditional Surgery Devices (Product)
  • Emerging Opportunity Segment: Minimal Invasive Glaucoma Surgery (Surgery Method) | Ophthalmic Clinics (End-use) | Diamond Knives (Product)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of glaucoma and age-related eye disorders increasing surgical intervention demand

An expanding population of older adults and the growing burden of glaucoma and other age-associated eye disorders are increasing the number of patients requiring effective disease management. The glaucoma surgery devices market will be supported as ophthalmic specialists increasingly rely on surgical interventions for patients whose disease progression cannot be adequately controlled through conservative treatment alone. Surgical devices enable physicians to improve aqueous humor outflow and reduce intraocular pressure, helping address a central clinical objective in glaucoma management. Greater awareness of the consequences of untreated disease, combined with the chronic nature of glaucoma and the risk of irreversible vision loss, is also strengthening demand for procedures that can provide sustained pressure control in appropriate patient populations.

Growing preference for surgical solutions over long-term pharmacological glaucoma management

Long-term dependence on topical glaucoma medications can present challenges related to adherence, administration frequency, ocular irritation, and the need for continuous disease management. As a result, clinicians and patients are increasingly considering procedural approaches when medication alone does not provide adequate control or creates difficulties with sustained treatment. The glaucoma surgery devices market is benefiting from this shift as minimally invasive and other surgical techniques provide additional options for managing intraocular pressure while potentially reducing reliance on multiple medications. Advances in device design and procedural techniques are also expanding the range of surgical approaches available to ophthalmologists, allowing treatment decisions to be tailored to disease severity, patient characteristics, and the desired balance between pressure reduction and procedural intervention.

Government-led vision care awareness and screening programs improving early diagnosis rates

Public health initiatives focused on eye health, routine vision screening, and awareness of glaucoma are helping more individuals recognize the importance of regular ophthalmic evaluation, particularly among populations at elevated risk. Earlier identification can increase the likelihood that patients receive timely clinical management before significant vision deterioration occurs, while improved referral pathways can connect diagnosed individuals with specialists capable of evaluating surgical treatment options. For the glaucoma surgery devices market, stronger screening activity can therefore expand the diagnosed patient pool and increase opportunities for intervention when disease progression or inadequate pressure control warrants a procedure. Educational campaigns can also improve understanding of glaucoma as a condition that may progress without obvious symptoms, encouraging individuals to seek assessment rather than waiting until substantial visual impairment becomes apparent.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of glaucoma and ocular diseases 1.50% Short term (≤ 2 yrs) North America, Europe Medium Fast
Technological advancements in minimally invasive glaucoma devices 1.60% Medium term (2–5 yrs) North America, Asia Pacific Low Moderate
Expansion of ophthalmic care infrastructure in emerging regions 1.60% Long term (5+ yrs) Asia Pacific, Latin America Low Slow
Rising prevalence of glaucoma and age-related eye disorders increasing surgical intervention demand 2.90% High North America, Asia Pacific High Near Term
Growing preference for surgical solutions over long-term pharmacological glaucoma management 2.50% High North America, Europe High Mid Term
Government-led vision care awareness and screening programs improving early diagnosis rates 2.30% Moderate Asia Pacific, Latin America Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Glaucoma Surgery Devices Market
Largest Region
North America
39.5% Market Share in 2026

North America (Largest Region)

The glaucoma surgery devices market was dominated by North America, which accounted for 39.50% in 2026, supported by advanced ophthalmic healthcare infrastructure, established surgical capabilities, and strong adoption of specialized technologies for glaucoma management. An aging population and increasing need for effective vision-preserving interventions are sustaining demand for surgical devices. Continued emphasis on minimally invasive procedures and technological advancement in ophthalmic care further strengthens the region’s market position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is experiencing the fastest growth, driven by expanding healthcare infrastructure, rising awareness of glaucoma diagnosis and treatment, and increasing access to specialized ophthalmic services. Growing investment in medical facilities is improving the availability of advanced surgical procedures, while an aging population is contributing to greater demand for glaucoma management. Broader adoption of modern surgical approaches is also supporting the regional expansion of glaucoma surgery devices.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Clinical Evidence Focus

Germany emphasizes glaucoma surgery devices supported by strong clinical validation and consistent surgical outcomes. Hospitals and ophthalmic specialists increasingly adopt advanced implants and precision instruments that enhance treatment quality and procedural efficiency.

France 🇫🇷

Specialized Surgical Practice

France supports the adoption of glaucoma surgery devices through specialized ophthalmology networks and hospital-based eye care services. French clinicians increasingly incorporate minimally invasive approaches while maintaining strong emphasis on long-term treatment effectiveness.

Italy 🇮🇹

Hospital Procedure Expansion

Italy is expanding the use of glaucoma surgery devices across specialized ophthalmic hospitals and surgical centers. Italian providers prioritize clinically proven technologies that improve procedural consistency and address the increasing demand for effective glaucoma treatment.

Japan 🇯🇵

Precision Ophthalmic Care

Japan prioritizes glaucoma surgery devices that deliver reliable outcomes for an aging patient population. Japanese ophthalmologists increasingly adopt minimally invasive techniques and advanced surgical tools that complement established eye care practices.

South Korea 🇰🇷

Technology-Driven Procedures

South Korea strengthens demand for glaucoma surgery devices through technologically advanced ophthalmology centers and specialized eye clinics. Healthcare providers increasingly seek innovative surgical platforms that improve procedural accuracy and patient care efficiency.

United States 🇺🇸

Minimally Invasive Adoption

The U.S. continues expanding the use of glaucoma surgery devices through growing adoption of minimally invasive procedures. Healthcare providers prioritize technologies that improve surgical precision, reduce recovery time, and support personalized treatment strategies for glaucoma management.

Segment Analysis

Segment Leadership and Growth Trends

Glaucoma Surgery Devices Market Share (%), by Surgery Method, 2026

Traditional Glaucoma Surgery
Minimal Invasive Glaucoma Surgery
Laser Surgery

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Surgery Method Segment Analysis: Traditional Glaucoma Surgery (Largest Segment) vs Minimal Invasive Glaucoma Surgery (Fastest-Growing Segment)

Traditional glaucoma surgery accounted for the largest share of the glaucoma surgery devices market in 2026, at 37.22%, supported by its established clinical role in managing patients with advanced or difficult-to-control glaucoma. Procedures such as trabeculectomy and glaucoma drainage interventions have well-established treatment protocols, broad physician familiarity, and proven effectiveness in reducing intraocular pressure. The availability of established surgical infrastructure and clinician experience continues to sustain demand for devices used in conventional glaucoma procedures.

Minimal invasive glaucoma surgery is gaining momentum as ophthalmologists and patients increasingly favor procedures that can provide effective intraocular pressure management with less tissue disruption and potentially faster recovery. The growing emphasis on safer, patient-friendly treatment approaches is encouraging adoption of minimally invasive techniques, particularly where earlier intervention can help manage disease progression. Continued development of specialized devices and greater clinical familiarity with these procedures are further supporting the segment's expansion.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ophthalmic Clinics (Fastest-Growing Segment)

Hospitals held the largest share of the glaucoma surgery devices market in 2026, accounting for 38.88%, due to their ability to provide comprehensive ophthalmic surgical services supported by specialized personnel, operating facilities, and postoperative care. Hospitals are particularly important for complex glaucoma cases that require advanced surgical capabilities and multidisciplinary support. Their established referral networks and capacity to manage patients across different stages of disease further reinforce their position as major users of glaucoma surgery devices.

Ophthalmic clinics are experiencing increasing demand as more glaucoma procedures shift toward specialized, outpatient-oriented care environments. Dedicated clinics can offer focused ophthalmic expertise, streamlined patient workflows, and convenient access to routine and minimally invasive procedures. The growing preference for specialized care and shorter treatment pathways is encouraging investment in ophthalmic surgical equipment, strengthening the role of these clinics in glaucoma management.

Segment Sub-Segment Largest Segment Fastest Growing
Surgery Method Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, Laser Surgery Traditional Glaucoma Surgery Minimal Invasive Glaucoma Surgery
End-use Hospitals, Ophthalmic Clinics, Others Hospitals Ophthalmic Clinics
Product Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, Others Traditional Surgery Devices Diamond Knives
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the glaucoma surgery devices market:

1. Alcon Inc. (Switzerland)

2. Glaukos Corporation (United States)

3. Carl Zeiss Meditec AG (Germany)

4. Lumenis Ltd. (Israel)

5. Iridex Corporation (United States)

6. AbbVie Inc. (United States)

7. BVI Medical (United States)

8. Ziemer Ophthalmic Systems AG (Switzerland)

Advances in minimally invasive ophthalmic procedures are strengthening the glaucoma surgery devices market, with research focused on precision surgical devices and improved intraocular pressure management. Technological innovation continues to enhance surgical safety and long-term patient outcomes.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Alcon Inc. (Switzerland)
Glaukos Corporation (United States)
Carl Zeiss Meditec AG (Germany)
Lumenis Ltd. (Israel)
Iridex Corporation (United States)
AbbVie Inc. (United States)
BVI Medical (United States)
Ziemer Ophthalmic Systems AG (Switzerland).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Ciliatech SAS Aug-25 Ciliatech SAS received CE certification under the EU Medical Device Regulation for its Intercil Uveal Spacer. The approval enables commercialization of the minimally invasive glaucoma implant across European markets, broadening the availability of implant-based surgical solutions for reducing intraocular pressure.
Alcon Feb-25 Alcon launched the Voyager Direct Selective Laser Trabeculoplasty system, described as the first fully automated glaucoma laser. The technology introduces greater procedural automation for glaucoma treatment and demonstrated medication-free outcomes at 12 months, supporting advancement in laser-based glaucoma care.
Sight Sciences Jan-25 Sight Sciences released long-term real-world clinical data demonstrating sustained intraocular pressure control using its OMNI Surgical System. The findings reinforce the system’s clinical utility in minimally invasive glaucoma surgery and support broader adoption in ophthalmic surgical practice.
Alcon Jul-24 Alcon completed its USD 81 million acquisition of Belkin Vision, expanding its glaucoma laser portfolio. The acquisition enhances Alcon’s capabilities in glaucoma surgery technologies and reinforces its competitive position in the ophthalmic devices market.
ViaLase Jul-24 ViaLase received CE mark approval for its femtosecond laser-based system enabling non-incisional trabeculotomy for glaucoma treatment. The technology supports significant intraocular pressure reduction and expands adoption of laser-based, incision-free glaucoma surgical approaches in European markets.
New World Medical May-24 New World Medical received FDA 510(k) clearance for expanded indications of its KDB GLIDE device, including standalone use for primary open-angle glaucoma. The approval broadens clinical applicability and strengthens adoption potential in minimally invasive glaucoma surgery procedures.
Glaukos Corporation Apr-24 Glaukos Corporation secured a permanent CMS J-code for iDose TR, improving reimbursement clarity and facilitating broader U.S. market access for its intracameral implant therapy used in intraocular pressure reduction for glaucoma and ocular hypertension patients.
Glaukos Corporation Dec-23 Glaukos received FDA approval for iDose TR, an intracameral travoprost implant indicated for reducing intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The approval represents a significant expansion of sustained drug-delivery options within glaucoma treatment.
Alcon Apr-22 Alcon acquired Ivantis Inc., adding the Hydrus Microstent to its ophthalmic surgical portfolio. The acquisition strengthened Alcon’s position in minimally invasive glaucoma surgery by expanding its range of implant-based treatment options for glaucoma management.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Glaucoma Surgery Devices Market — Custom Segments

Segment Sub-Segment
Glaucoma Type Open-Angle Glaucoma, Angle-Closure Glaucoma, Secondary Glaucoma
Reimbursement Coverage Fully Reimbursed, Partially Reimbursed, Self-Pay
Purchase Model Capital Equipment Purchase, Procedure-Based Procurement, Consignment-Based Procurement

Glaucoma Surgery Devices Market — Custom TOC

Custom Chapter Custom Details
Minimally Invasive Glaucoma Surgery (MIGS) Opportunities
  • Clinical Adoption Landscape
  • Technology Innovation Pipeline
  • Procedure Expansion Across Care Settings
  • Commercial Opportunity Assessment
  • Future Innovation Outlook
Ophthalmology Practice Transformation
  • Evolution of Surgical Care Delivery
  • Ambulatory Surgery Center Expansion
  • Digital Integration in Ophthalmic Practices
  • Practice Efficiency and Workflow Optimization
Patient Access and Procedure Growth
  • Diagnosis-to-Treatment Journey
  • Referral Network Evolution
  • Healthcare Access and Affordability Factors
  • Procedure Adoption Drivers
  • Untapped Growth Opportunities

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How much is the glaucoma surgery devices market worth?

As of 2027 the market size of glaucoma surgery devices is valued at USD 1.97 billion.

How will the glaucoma surgery devices industry grow in terms of size and CAGR by 2036?

Glaucoma Surgery Devices Market size was worth USD 1.9 billion in 2026 and is poised to grow at a 4.37% CAGR between 2027 and 2036, crossing USD 2.91 billion by 2036.

Why is minimally invasive glaucoma surgery gaining strategic importance in the glaucoma surgery devices market?

Providers are increasingly adopting minimally invasive procedures to improve workflow efficiency, reduce procedural burden, and support earlier intervention, encouraging stronger demand for surgeon-friendly implants and device-based treatment systems.

How are early diagnosis initiatives influencing demand in the glaucoma surgery devices market?

Vision screening and awareness programs are expanding the diagnosed patient population, increasing referrals for specialist care and encouraging healthcare providers to invest in surgical technologies that support growing procedural volumes.

Why does traditional glaucoma surgery remain the largest segment in the glaucoma surgery devices market?

Traditional glaucoma surgery held a 37.22% share in 2026 due to its established role in managing advanced glaucoma cases that require substantial intraocular pressure reduction and proven clinical outcomes.

Which end-use segment is growing the fastest in the glaucoma surgery devices market?

Ophthalmic clinics are the fastest-growing end-use segment as more glaucoma procedures shift to specialized outpatient settings focused on efficiency, patient convenience, and minimally invasive techniques.

Why is North America the leading region in the glaucoma surgery devices market?

North America accounted for 39.50% of the market in 2026, supported by advanced ophthalmic infrastructure, high procedure volumes, and widespread adoption of surgical glaucoma treatments.

How is Asia Pacific expanding the glaucoma surgery devices market?

Asia Pacific is projected to grow at a 5.36% CAGR as improving ophthalmic care access, expanding hospital capacity, and broader availability of modern glaucoma procedures increase device adoption.

What are the key competitors in the glaucoma surgery devices landscape?

Top companies in the glaucoma surgery devices market include Alcon Inc. (Switzerland), Glaukos Corporation (United States), Carl Zeiss Meditec AG (Germany), Lumenis Ltd. (Israel), Iridex Corporation (United States), AbbVie Inc. (United States), BVI Medical (United States), Ziemer Ophthalmic Systems AG (Switzerland).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →